Prescient Therapeutics (PTX) News Today → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free PTX Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 25, 2024 | msn.comPrescient ETF Adds New Securities to Its Income Provider Feeder FundMay 22, 2024 | msn.comPrescient Income Provider Feeder ETF Expands with New SecuritiesMay 20, 2024 | msn.comPrescient Expands Its Income Provider Feeder ETF PortfolioMay 18, 2024 | msn.comPrescient ETF Increases Securities with New ListingMay 18, 2024 | msn.comPrescient helps Reatile with equity injection to acquire a stake in Ursa EnergyMay 16, 2024 | investing.comPrescient Therapeutics Ltd (PTX)May 15, 2024 | msn.comPrescient Management Lists Additional PMXINC Securities on JSEApril 26, 2024 | msn.comPrescient Management Issues Over 114,000 New Securities in PMXINC ETFApril 18, 2024 | msn.comPrescient Management Expands Portfolio with Additional PMXINC Securities ListingApril 6, 2024 | msn.comPrescient Management Expands PIPETF Securities in the MarketApril 4, 2024 | msn.comPrescient ETF Expands Offering with Additional Securities ListingMarch 26, 2024 | msn.comPrescient ETF Expands with New Listings in Global Property PortfolioMarch 15, 2024 | msn.comPrescient ETF Expands with New Securities ListingMarch 6, 2024 | finance.yahoo.comWe're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash WiselyFebruary 1, 2024 | afr.comPrescient Therapeutics LimitedDecember 10, 2023 | au.investing.comPrescient Therapeutics’ PTX-100 Phase 1b study shows excellent safety and promising efficacy in T-cell lymphoma patientsNovember 20, 2023 | msn.comMoneyTalks: Prescient set for ‘big pay day’; Aerometrex to grab ‘blue ocean’ AI opportunityNovember 16, 2023 | proactiveinvestors.com.auPrescient Therapeutics nearing a potential payday with PTX-100: Pitt Street ResearchNovember 6, 2023 | au.investing.comPrescient Therapeutics to participate in prestigious conference; abstract online nowOctober 31, 2023 | msn.comCancer fighter Prescient navigates challenging conditions for biotech, reports strong Q1 FY24October 17, 2023 | msn.comPrescient prepares to unveil Phase 1b cancer trial findings at world’s largest haematology conferenceOctober 16, 2023 | proactiveinvestors.com.auPrescient Therapeutics to present clinical data at prestigious US conferenceSeptember 19, 2023 | msn.comASX cancer stocks guide: Here’s everything you need to knowAugust 30, 2023 | msn.com‘Above and beyond approved therapies’: How Prescient Therapeutics is at the forefront of cancer fightingJune 16, 2023 | finance.yahoo.comPrescient Therapeutics showcases cell therapy data at prestigious ISCT conferenceMay 15, 2023 | proactiveinvestors.com.auPrescient Therapeutics to present CellPryme and OmniCAR data to International Society of Cell and Gene TherapyMay 15, 2023 | proactiveinvestors.com.auPrescient Therapeutics bolsters board with appointment of experienced US-based pharma executiveApril 20, 2023 | finance.yahoo.comPrescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth PlansMarch 16, 2023 | proactiveinvestors.com.auPrescient Therapeutics' PTX-100 T Cell Lymphoma Phase 1b trial continues to show promising resultsMarch 15, 2023 | msn.comASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good resultsMarch 9, 2023 | proactiveinvestors.com.auPrescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100March 8, 2023 | msn.comGuess which ASX biotech stock just rocketed 29% on big FDA newsMarch 8, 2023 | proactiveinvestors.comPrescient Therapeutics granted US FDA additional Orphan Drug Designation for PTX-100; shares upNovember 22, 2022 | finance.yahoo.comHere's Why Shareholders Will Not Be Complaining About Prescient Therapeutics Limited's (ASX:PTX) CEO Pay PacketNovember 12, 2022 | finance.yahoo.comHere's Why We're Not Too Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn SituationNovember 1, 2022 | proactiveinvestors.com.auPrescient Therapeutics provides PTX-100 trial update, readies for investor briefingOctober 25, 2022 | proactiveinvestors.com.auPrescient Therapeutics PTX-100 continues to exhibit excellent safety profileOctober 11, 2022 | yahoo.comProactive news headlines including AuTECO Minerals, Provaris Energy, Moho Resources and Prescient TherapeuticsOctober 10, 2022 | proactiveinvestors.com.auPrescient Therapeutics A$2.5 million top-up placement brings raise total to A$11.3 millionOctober 7, 2022 | proactiveinvestors.comPrescient Therapeutics exceeds SPP target, delivers top-up placement to accommodate demandSeptember 11, 2022 | proactiveinvestors.com.auPrescient Therapeutics hails collaboration with MD Anderson Cancer Center for blood cancer therapySeptember 7, 2022 | proactiveinvestors.com.auPrescient Therapeutics to collaborate with largest cancer centre in the US to develop blood cancer treatmentSeptember 2, 2022 | proactiveinvestors.com.auPrescient Therapeutics announces share purchase plan to raise $8 millionAugust 24, 2022 | fool.com.auWhy is the Prescient share price diving 12% on Wednesday?August 18, 2022 | proactiveinvestors.com.auPrescient developing "the next generation of OmniCAR cells" with Thermo Fisher ScientificAugust 17, 2022 | proactiveinvestors.com.auPrescient Therapeutics set to create scalable cell therapy platform with Thermo Fisher ScientificAugust 16, 2022 | proactiveinvestors.com.auPrescient Therapeutics enters into OmniCAR cell production agreement with Q-Gen CellAugust 13, 2022 | finance.yahoo.comPrescient Therapeutics Limited (PTX.AX)August 3, 2022 | proactiveinvestors.com.auChallenging the pace of change in healthcare: Prescient TherapeuticsJuly 15, 2022 | finance.yahoo.comProactive news headlines including Legacy Minerals, Matador Mining, Carnavale Resources and Prescient Therapeutics Get Prescient Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter. Email Address The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. PTX Media Mentions By Week PTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTX News Sentiment▼0.000.77▲Average Medical News Sentiment PTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTX Articles This Week▼00▲PTX Articles Average Week Get Prescient Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News Baseline Productions News BerGenBio ASA News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:PTX) was last updated on 6/3/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBill Gates is all about this tiny $2 stockTimothy SykesBiden Nomination CANCELED?The Freeport SocietyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTradeShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prescient Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.